Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells

Microb Cell Fact. 2012 May 24:11:67. doi: 10.1186/1475-2859-11-67.

Abstract

Background: We present the potential of inclusion bodies (IBs) as a protein delivery method for polymeric filamentous proteins. We used as cell factory a strain of E. coli, a conventional host organism, and keratin 14 (K14) as an example of a complex protein. Keratins build the intermediate filament cytoskeleton of all epithelial cells. In order to build filaments, monomeric K14 needs first to dimerize with its binding partner (keratin 5, K5), which is then followed by heterodimer assembly into filaments.

Results: K14 IBs were electroporated into SW13 cells grown in culture together with a "reporter" plasmid containing EYFP labeled keratin 5 (K5) cDNA. As SW13 cells do not normally express keratins, and keratin filaments are built exclusively of keratin heterodimers (i.e. K5/K14), the short filamentous structures we obtained in this study can only be the result of: a) if both IBs and plasmid DNA are transfected simultaneously into the cell(s); b) once inside the cells, K14 protein is being released from IBs; c) released K14 is functional, able to form heterodimers with EYFP-K5.

Conclusions: Soluble IBs may be also developed for complex cytoskeletal proteins and used as nanoparticles for their delivery into epithelial cells.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Delivery Systems / methods*
  • Electroporation
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Humans
  • Inclusion Bodies / genetics
  • Inclusion Bodies / metabolism*
  • Intermediate Filaments / genetics
  • Intermediate Filaments / metabolism
  • Keratin-14 / genetics
  • Keratin-14 / metabolism
  • Keratin-14 / therapeutic use
  • Keratin-5 / genetics
  • Keratin-5 / metabolism
  • Protein Transport
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism*
  • Recombinant Proteins / therapeutic use

Substances

  • Keratin-14
  • Keratin-5
  • Recombinant Proteins